Skip to content

An exploratory randomized controlled study of electroacupuncture in the treatment of chronic colitis based on the theory of acupoint sensitization

An exploratory randomized controlled study of electroacupuncture in the treatment of chronic colitis based on the theory of acupoint sensitization

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000122
Enrollment
Unknown
Registered
2024-07-09
Start date
2024-03-21
Completion date
Unknown
Last updated
2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic colitis

Interventions

Control 2 groups:No electroacupuncture interventions were performed during the 4-week treatment and follow-up 4-week periods using conventional treatments.
Control 1 groups:The patients were treated with electroacupuncture on the basis of conventional treatment, and the stimulation sites were the middle epigastric region, the Tianshu, the foot Sanli, and
intervention group:Patients were treated with electroacupuncture on the basis of conventional treatment to stimulate the sensitized sites (4 in total), and the first four points with the most pronounc

Sponsors

Shaanxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for chronic colitis (i.e., clinical manifestations of recurrent abdominal pain, diarrhea and loose stools (or constipation), with no or only a small amount of blood or mucus in the stools, and no or mild systemic symptoms; local congestion, edema, or scattered erythema and erosions visible by colonoscopy; and chronic inflammatory changes in the histopathological examination of the colonic mucosa). (2) Sex is not limited, age between 18-65 years old; (3) Those who are willing to participate in the trial and sign the informed consent; Note: Patients who meet the above 3 items at the same time can be included in this study.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the diagnostic criteria and the criteria for inclusion of cases; (2) Those with previous myocardial infarction, severe heart failure, valvular heart disease, severe arrhythmia primary cardiomyopathy, hematologic diseases; and those with other serious cerebrovascular diseases. (3) Pregnant and lactating women, and patients with mental diseases who are unable to cooperate; (4) Patients with combined intestinal tuberculosis, bacterial dysentery, radiation colitis, and malignant tumors; (5) Those who participate in other clinical trials at the same time; (6) Patients who are allergic to needles; (7) Those who have received acupuncture treatment in the last three months; Note: Anyone who meets any of the above will be excluded.

Design outcomes

Primary

MeasureTime frame
Quantitative Criteria Points for Symptom Grading;

Secondary

MeasureTime frame
(Visceral Sensitivity Index,VSI);(IBS-SSS);Graded colonoscopic observation;(SAS\SDS);

Countries

China

Contacts

Public ContactQiao Haifa

Shaanxi University of Chinese Medicine

1511006@sntcm.edu.cn18220046518

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026